Regulatory AZ, Amgen will pilot FDA’s real-time clinical trial plan PharmaphorumThe FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time.Read full story pharminent April 29, 2026 (Last updated: April 29, 2026) Pharmaphorum The FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time. Read full story Post navigation Previous: AstraZeneca faces uphill battle at upcoming adcomm in face of FDA questionsNext: Pfizer settles with generic drugmakers to protect blockbuster drug until 2031 Related Stories Regulatory Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa pharminent August 20, 2026 Regulatory Regeneron wins FDA approval to challenge Ipsen for rare bone disease market pharminent August 20, 2026 Regulatory FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy pharminent August 20, 2026
